Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$594K Sell
63,613
-6,534
-9% -$60.7K ﹤0.01% 925
2026
Q1
$702K Buy
70,147
+1,069
+2% +$11.1K ﹤0.01% 846
2025
Q4
$698K Buy
+69,078
New +$657K ﹤0.01% 833
2025
Q1
$529K Sell
51,449
-1,317
-2% -$13K ﹤0.01% 891
2024
Q4
$503K Sell
52,766
-7,682
-13% -$75.2K ﹤0.01% 933
2024
Q3
$640K Sell
60,448
-265
-0.4% -$2.56K ﹤0.01% 852
2024
Q2
$501K Sell
60,713
-71
-0.1% -$593 ﹤0.01% 904
2024
Q1
$516K Buy
60,784
+4,649
+8% +$38.9K ﹤0.01% 915
2023
Q4
$462K Buy
56,135
+1,312
+2% +$10.8K ﹤0.01% 923
2023
Q3
$457K Sell
54,823
-8,590
-14% -$71.5K ﹤0.01% 867
2023
Q2
$516K Hold
63,413
﹤0.01% 822
2023
Q1
$516K Sell
63,413
-642
-1% -$5.12K ﹤0.01% 826
2022
Q4
$512K Sell
64,055
-4,834
-7% -$32.9K ﹤0.01% 827
2022
Q3
$419K Buy
+68,889
New +$446K ﹤0.01% 852

Other funds holding HLN

Glenmede Trust's HLN Position: Q2 2026 in Review

Glenmede Trust reduced its Haleon (HLN) stake by 9.3% in Q2 2026, selling an estimated $60.7K and leaving 63,613 shares worth $594K. The position accounts for ﹤0.01% of the portfolio, ranked #925.

Glenmede Trust first reported a position in HLN in Q3 2022 and has held it in 14 quarters since. The position peaked at $702K in Q1 2026. 639 funds tracked by Wall St. Rank hold HLN as of Q2 2026.

  • Glenmede Trust held 63,613 shares of Haleon worth $594K as of Q2 2026.
  • Glenmede Trust sold 6,534 Haleon shares in Q2 2026, an estimated $60.7K.
  • Haleon made up ﹤0.01% of Glenmede Trust's portfolio in Q2 2026, its #925 holding.
  • Glenmede Trust first reported a position in Haleon in Q3 2022 and has held it in 14 quarters since.
  • Glenmede Trust's Haleon position peaked at $702K in Q1 2026.
  • 639 funds tracked by Wall St. Rank held Haleon as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.